Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy Alliance
These vaccine MAP priorities will inform the investment decisions of MAP developers, vaccine manufacturers, donors, and global health partners to better respond to country needs when designing their MAP portfolios. By providing a holistic assessment of the potential drivers for and key risks of developing specific vaccine MAPs, our findings have the potential to promote MAP development activities for vaccines that are priorities for LMICs.
Authors
- Mateusz Hasso-Agopsowicz (ORCID: https://orcid.org/0000-0003-4137-4685)
- Courtney Jarrahian (ORCID: https://orcid.org/0000-0003-3046-6891)
- Jessica Mistilis (ORCID: https://orcid.org/0000-0002-1448-278X)
- Tiziana Scarnà
- Collrane Frivold (ORCID: https://orcid.org/0000-0002-2000-5429)
- Kristen Earle (ORCID: https://orcid.org/0000-0002-2956-8025)
- Birgitte Giersing (ORCID: https://orcid.org/0000-0003-2555-7756)
- Marion Menozzi-Arnaud (ORCID: https://orcid.org/0000-0001-7878-5598)
- Mercy Mvundura (ORCID: https://orcid.org/0000-0002-7711-9558)
- Jean‐Pierre Amorij
Institutions
- United Nations Children's Fund (US)
- Gates Foundation (US)
- Program for Appropriate Technology in Health (US)
- Gavi (CH)
- World Health Organization (CH)
- United Nations Children's Fund India (IN)
Publication Details
- Journal
- Vaccine
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1016/j.vaccine.2025.126996
- Citations
- 3
- Primary Topic
- Transgenic Plants and Applications
- Type
- article
- Field-Weighted Citation Impact
- 3.70
Funders
- Bill and Melinda Gates Foundation